The antibiotic susceptibility patterns of uropathogens among adults with recurrent urinary tract infection in Mosul, Iraq
DOI:
https://doi.org/10.60988/p.v36i2.59Abstract
The emergence of bacteria resistant to antimicrobial treatments can lead to prolonged hospitalization, increased financial costs, and even mortality. One of the most common bacterial infections, both in hospital and community settings, is recurrent urinary tract infections (UTIs). This study aimed to investigate the antibiotic resistance patterns of the most commonly used antibiotics and identify the causative uropathogenic bacteria isolated from the urine of patients suffering from recurrent UTIs. The study recruited 77 patients diagnosed with recurrent UTIs who had not received antibiotic therapy in the last 14 days, and collected urine samples for analysis. Using the disk diffusion method per the Clinical and Laboratory Standards Institute’s guidelines, the study found that Escherichia coli was the most common uropathogens identified in all patients (51.94%), followed by Staphylococcus aureus (20.77%), K. pneumoniae (9.09%), Proteus spp. (7.79%), Enterobacter (6.49%), and P. aeruginosa (3.89%). Alarmingly, all of the isolated bacterial uropathogens were found to be resistant to at least five of the tested antibiotics. The findings of this study have important implications for the treatment of recurrent UTIs, as they provide valuable information on antibiotic resistance patterns and uropathogenic bacteria that can inform the development of more effective antibiotic regimens. This knowledge will empower physicians with the information they need to make informed decisions when treating recurrent UTIs.
References
REFERENCES
Al-Zidan R., Abdulrazzaq G.., Al-Shakarchi W. Antibiotic misuse and the development of bacterial resistance: Are we losing the battle? Iraqi J. Pharm.16(1), 73–84, 2019
Foxman B. The epidemiology of urinary tract infection. Nat. Rev. Urol. 7(12), 653–60, 2010 http://dx.doi.org/10.1038/nrurol.2010.190
Medina M.., Castillo-Pino E. An introduction to the epidemiology and burden of urinary tract infections. Ther. Adv. Urol. 11(6), 175628721983217, 2019 http://journals.sagepub.com/doi/10.1177/1756287219832172
Öztürk R.., Murt A. Epidemiology of urological infections: a global burden. World J. Urol. 38(11), 2669–79, 2020 https://doi.org/10.1007/s00345-019-03071-4
Stamm W.E.., Norrby S.R. Urinary tract infections: Disease panorama and challenges. J. Infect. Dis. 183, S1–4, 2001.
Flores-Mireles A.L., Walker J.N., Caparon M.., Hultgren S.J. Urinary tract infections: Epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 13(5), 269–84, 2015.
Elias C., Moja L., Mertz D., Loeb M., Forte G.., Magrini N. Guideline recommendations and antimicrobial resistance: The need for a change. BMJ Open. 7(7), 1–8, 2017.
CLSI. CLSI M100-ED29: (2021) Performance Standards for Antimicrobial Susceptibility Testing, 30th Edition. Clsi. 40, 50–51 , 2020
Frost I., Laxminarayan R., McKenna N., Chai S.., Joshi J. Antimicrobial resistance and primary health care. World Heal. Organ., 3–6, 2018 https://apps.who.int/iris/bitstream/handle/10665/326454/WHO-HIS-SDS-2018.56-eng.pdf%0Ahttps://www.who.int/docs/default-source/primary-health-care-conference/amr.pdf?sfvrsn=8817d5ba_2
Isberg H.K., Hedin K., Melander E., Mölstad S.., Beckman A. Increased adherence to treatment guidelines in patients with urinary tract infection in primary care: A retrospective study. PLoS One. 14(3), 1–12, 2019.
Muhammad A., Khan S.N., Ali N., Rehman M.U.., Ali I. Prevalence and antibiotic susceptibility pattern of uropathogens in outpatients at a tertiary care hospital. New Microbes New Infect. 36, 100716, 2020. https://doi.org/10.1016/j.nmni.2020.100716
Foxman B. Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. Disease-a-Month. 49(2), 53–70, 2003.
Walker E., Lyman A., Gupta K., Mahoney M. V., Snyder G.M.., Hirsch E.B. Clinical Management of an Increasing Threat: Outpatient Urinary Tract Infections Due to Multidrug-Resistant Uropathogens. Clin. Infect. Dis. 63(7), 960–5, 2016.
Deulofeu F., Cervelló B., Capell S., Martí C.., Mercadé V. Predictors of mortality in patients with bacteremia: The importance of functional status. J. Am. Geriatr. Soc. 46(1), 14–8, 1998.
Chu C.M.., Lowder J.L. Diagnosis and treatment of urinary tract infections across age groups. Am. J. Obstet. Gynecol. 219(1), 40–51, 2018 https://doi.org/10.1016/j.ajog.2017.12.231
Hozzari A., Behzadi P., Kerishchi Khiabani P., Sholeh M.., Sabokroo N. Clinical cases, drug resistance, and virulence genes profiling in Uropathogenic Escherichia coli. J. Appl. Genet. 61(2), 265–73, 2020.
Yilmaz Y., Tekkanat Tazegun Z., Aydin E.., Dulger M. Bacterial uropathogens causing urinary tract infection and their resistance patterns among children in Turkey. Iran. Red Crescent Med. J. 18(6), 4–7, 2016.
Bi X.C., Zhang B., Ye Y.K., He H.C., Han Z.D., Dai Q.S., et al. Pathogen incidence and antibiotic resistance patterns of catheter-associated urinary tract infection in children. J. Chemother. 21(6), 661–5, 2009.
Tessema B., Kassu A., Mulu A.., Yismaw G. Pridominant isolates of urinary tract pathogens and their antimicrobial susceptiblity patterns in Gondar University Teaching Hospital, nothwest Ethiopia. Ethiop. Med. J. 45(1), 61–7, 2007. https://europepmc.org/article/med/17642159
Bazaid A.S., Saeed A., Alrashidi A., Alrashidi A., Alshaghdali K., Hammam S.A., et al. Antimicrobial surveillance for bacterial uropathogens in Ha’il, Saudi Arabia: A five-year multicenter retrospective study. Infect. Drug Resist. 14, 1455–65, 2021.
Jakes A., McCue E.., Cracknell A. Improving mid stream urine sampling: reducing labelling error and laboratory rejection. BMJ Qual. Improv. Reports. 3(1), u204759.w2219, 2014.
Mason C.Y., Sobti A.., Goodman A.L. Staphylococcus aureus bacteriuria: Implications and management. JAC-Antimicrobial Resist. 5(1), 1–6, 2023 https://doi.org/10.1093/jacamr/dlac123
Manoni F., Gessoni G., Alessio M.G., Caleffi A., Saccani G., Silvestri M.G., et al. Mid-stream vs. first-voided urine collection by using automated analyzers for particle examination in healthy subjects: An Italian multicenter study. Clin. Chem. Lab. Med. 50(4), 679–84, 2012.
Blake D.R.., Doherty L.F. Effect of perineal cleansing on contamination rate of mid-stream urine culture. J. Pediatr. Adolesc. Gynecol. 19(1), 31–4, 2006.
Gupta K., Sahm D.F., Mayfield D.., Stamm W.E. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: A nationwide analysis. Clin. Infect. Dis. 33(1), 89–94, 2001.
Critchley I.A., Cotroneo N., Pucci M.J., Jain A.., Mendes R.E. Resistance among urinary tract pathogens collected in Europe during 2018. J. Glob. Antimicrob. Resist. 23, 439–44, 2020. https://doi.org/10.1016/j.jgar.2020.10.020
Goossens H., Ferech M., Vander Stichele R.., Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 365(9459), 579–87, 2005. https://linkinghub.elsevier.com/retrieve/pii/S0140673605179070
Khoshnood S., Heidary M., Mirnejad R., Bahramian A., Sedighi M.., Mirzaei H. Drug-resistant gram-negative uropathogens: A review. Biomed. Pharmacother. 94, 982–94, 2017. http://dx.doi.org/10.1016/j.biopha.2017.08.006
Demir M.., Kazanasmaz H. Uropathogens and antibiotic resistance in the community and hospital-induced urinary tract infected children. J. Glob. Antimicrob. Resist. 20, 68–73, 2020. https://doi.org/10.1016/j.jgar.2019.07.019
Costelloe C., Metcalfe C., Lovering A., Mant D.., Hay A.D. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: Systematic review and meta-analysis. BMJ. 340(7756), 1120, 2010.
Gajamer V.R., Bhattacharjee A., Paul D., Ingti B., Sarkar A., Kapil J., et al. High prevalence of carbapenemase, AmpC β-lactamase and aminoglycoside resistance genes in extended-spectrum β-lactamase-positive uropathogens from Northern India. J. Glob. Antimicrob. Resist. 20, 197–203, 2020. https://doi.org/10.1016/j.jgar.2019.07.029
Nguyen H.M.., Graber C.J. A Critical Review of Cephalexin and Cefadroxil for the Treatment of Acute Uncomplicated Lower Urinary Tract Infection in the Era of “Bad Bugs, Few Drugs.” Int. J. Antimicrob. Agents. 56(4), 106085, 2020. https://doi.org/10.1016/j.ijantimicag.2020.106085
Rodríguez-Gascón A., Aguirre-Quiñonero A.., Canut-Blasco A. Are oral cefuroxime axetil, cefixime and cefditoren pivoxil adequate to treat uncomplicated acute pyelonephritis after switching from intravenous therapy? A pharmacokinetic/pharmacodynamic perspective. Enferm. Infecc. Microbiol. Clin. (Engl. Ed.). 38(7), 306–11, 2020.
M. AbdulRazzaq G. Pattern of antibiotic sensitivity and resistance of uropathogenes among pediatric patients with urinary tract infection. Iraqi J. Pharm. 13(1), 64–76, 2013.
Assafi M.S., Ali F.F., Polis R.F., Sabaly N.J.., Qarani S.M. An epidemiological and multidrug resistance study for e. coli isolated from urinary tract infection (three years of study). Baghdad Sci. J. 19(1), 7–15, 2022.
White C.R., Jodlowski T.Z., Atkins D.T., Holland N.G. Successful Doxycycline Therapy in a Patient with Escherichia coli and Multidrug-Resistant Klebsiella pneumoniae Urinary Tract Infection. J. Pharm. Pract. 30(4), 464–7, 2017.
